Annika Rossler
Overview
Explore the profile of Annika Rossler including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
916
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Brangel P, Tureli S, Muhlemann B, Liechti N, Zysset D, Engler O, et al.
Viruses
. 2025 Jan;
16(12).
PMID: 39772242
Setting up a global SARS-CoV-2 surveillance system requires an understanding of how virus isolation and propagation practices, use of animal or human sera, and different neutralisation assay platforms influence assessment...
2.
Rossler A, Netzl A, Lasrado N, Chaudhari J, Muhlemann B, Wilks S, et al.
Cell Rep
. 2025 Jan;
44(1):115140.
PMID: 39754717
Virus neutralization profiles against primary infection sera and corresponding antigenic cartography are integral part of the COVID-19 and influenza vaccine strain selection processes. Human single variant exposure sera have previously...
3.
Rossler A, Netzl A, Knabl L, Wilks S, Muhlemann B, Tureli S, et al.
NPJ Vaccines
. 2024 May;
9(1):85.
PMID: 38762525
Antigenic characterization of newly emerging SARS-CoV-2 variants is important to assess their immune escape and judge the need for future vaccine updates. To bridge data obtained from animal sera with...
4.
Muhlemann B, Wilks S, Baracco L, Bekliz M, Carreno J, Corman V, et al.
Sci Transl Med
. 2024 May;
16(747):eadl1722.
PMID: 38748773
The evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) requires ongoing monitoring to judge the ability of newly arising variants to escape the immune response. A surveillance system necessitates...
5.
Zollner A, Koch R, Jukic A, Pfister A, Meyer M, Wick N, et al.
Gastroenterology
. 2024 Apr;
167(3):604-607.e8.
PMID: 38631418
No abstract available.
6.
Kimpel J, Rossler A, Bante D, Borena W, von Laer D, Zehetner C, et al.
Front Cell Infect Microbiol
. 2024 Mar;
14:1332157.
PMID: 38500504
Introduction: SARS-CoV-2 is known to infect respiratory tissue cells. However, less is known about infection of ocular tissue and potential infectivity of lacrimal fluid. With this study, we want to...
7.
Lasrado N, Rossler A, Rowe M, Collier A, Barouch D
Vaccine
. 2024 Mar;
42(9):2117-2121.
PMID: 38458874
A new highly mutated Omicron subvariant BA.2.87.1 has recently been identified with over 30 amino acid mutations in the Spike protein compared with BA.2, BA.5, XBB.1.5, and JN.1 variants. Mutiple...
8.
Watschinger C, Stampfel G, Zollner A, Hoog A, Rossler A, Reiter S, et al.
Viruses
. 2024 Jan;
16(1).
PMID: 38275936
(1) Background: Vulnerable populations including transplant recipients are jeopardised by COVID-19. Herein, we report on B and T cell responses among liver and kidney organ recipients at our centre. (2)...
9.
Fischhuber K, Banki Z, Kimpel J, Kragl N, Rossler A, Bolze A, et al.
Viruses
. 2023 Dec;
15(12).
PMID: 38140540
The Coronavirus Disease 2019 (COVID-19) pandemic and the subsequent increase in respiratory viral infections highlight the need for broad-spectrum antivirals to enable a quick and efficient reaction to current and...
10.
Rossler A, Knabl L, Netzl A, Bante D, Borena W, von Laer D, et al.
J Infect Dis
. 2023 Nov;
229(3):644-647.
PMID: 38016020
We analyzed neutralizing antibodies in samples from ancestral + BA.1 and ancestral + BA.4/5 boosted individuals, collected around 5.5 months after booster. Titers of neutralizing antibodies generally decreased compared to...